Nasdaq:US$15.21 (-0.78) | HKEX:HK$24.20 (+0.50) | AIM:£2.44 (+0)
News & Presentations
Previous Article   |   Next Article
Announcements & Press Releases, Regulatory Notice | 19 Mar 2018

Director’s Share Dealing

London: Monday, March 19, 2018: Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has received notification that Dr Dan Eldar, Non-executive Director, purchased a total of 2,768 American Depositary Shares of the Company (“ADSs”, each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med) on March 14, 2018 at an average price of US$36.11 per ADS.

Following the above purchase, Dr Eldar is interested in 8,993 ADSs and 1,900 Ordinary Shares, representing approximately 0.0096% of the current issued share capital of Chi-Med.

Please download the full announcement for the notification as provided in accordance with the requirements of the EU Market Abuse Regulation.